drugset / Trial / NCT04005079

Pilocarpine After Combined Cataract/Trabectome Surgery

NCT04005079

Phase 3 Withdrawn Montefiore Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

Combined cataract + trabectome surgery is a surgery designed to help lower the intraocular pressure (pressure in the eye) and hopefully reduce the need for topical drops, progression of glaucoma, and/or further glaucoma surgeries. The purpose of this study is to assess whether using pilocarpine, a medication which is FDA approved to induce miosis, (in other words cause the pupil to constrict or become smaller) provides additional benefit to the success of Trabectome and cataract surgery.

Timeline

Start
2019-06-05
Primary completion
2021-01-21
Completion
2021-01-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Pilocarpine Unknown 2 %
Background Ofloxacin Small molecule
Background Prednisolone Other / unclassified